NANT CANCER VACCINE Trademark
NANT CANCER VACCINE is a USPTO trademark filed by Nant Holdings IP, LLC. Status: Registered.
Trademark Facts
| Mark | NANT CANCER VACCINE |
|---|---|
| Serial Number | 97599709 |
| Registration Number | 7491160 |
| Status | Registered |
| Filing Date | 2022-09-20 |
| Registration Date | 2024-09-03 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Nant Holdings IP, LLC |
| Attorney of Record | Michael J. McCue |
| Prosecution Events | 22 |
| Latest Event | R.PR on 2024-09-03 |
Goods & Services
Class 005: pharmaceutical preparations and substances for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, vaccine preparations; low-dose chemotherapeutics, low dose radiopharmaceutical preparations, and personalized neoepitope-targeted pharmaceutical preparations for medical use for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biological preparations, namely, cell-derived preparations, cell therapeutics, monoclonal antibodies, cytokines, immune modulators, low-dose chemotherapeutics, low-dose radiation therapeutics, antibodies, fusion proteins, peptide and cytokine biological preparations, vaccines, personalized neoepitope-based therapeutics, and natural killer cell derived preparations, for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, autoimmune diseases, infectious diseases, animal diseases, and cancer for clinical, medicinal, therapeutic, and veterinary purposes; kits comprising cell cultures, reagents and related instructions, for use in the treatment and prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, autoimmune diseases, infectious diseases, animal diseases and cancer, for clinical, medicinal, therapeutic and veterinary purposes